Prehospital care for ovarian cancer in Catalonia: could we do better in primary care? Retrospective cohort study

Objective To assess the impact of prehospital factors (diagnostic pathways, first presentation to healthcare services, intervals, participation in primary care) on 1-year and 5-year survival in people with epithelial ovarian cancer (EOC).Design Retrospective quasi-population-based cohort study.Setti...

Full description

Saved in:
Bibliographic Details
Main Authors: Mercè Marzo-Castillejo, Josep M Borras, Carmen Vela-Vallespín, Paula Manchon‐Walsh, Luisa Aliste
Format: Article
Language:English
Published: BMJ Publishing Group 2022-07-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/12/7/e060499.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832576736111362048
author Mercè Marzo-Castillejo
Josep M Borras
Carmen Vela-Vallespín
Paula Manchon‐Walsh
Luisa Aliste
author_facet Mercè Marzo-Castillejo
Josep M Borras
Carmen Vela-Vallespín
Paula Manchon‐Walsh
Luisa Aliste
author_sort Mercè Marzo-Castillejo
collection DOAJ
description Objective To assess the impact of prehospital factors (diagnostic pathways, first presentation to healthcare services, intervals, participation in primary care) on 1-year and 5-year survival in people with epithelial ovarian cancer (EOC).Design Retrospective quasi-population-based cohort study.Setting Catalan Integrated Public Healthcare System.Participants People with EOC who underwent surgery with a curative intent in public Catalan hospitals between 1 January 2013 and 31 December 2014.Outcome measures Data from primary and secondary care clinical histories and care processes in the 18 months leading up to confirmation (signs and symptoms at presentation, diagnosis pathways, referrals, diagnosis interval) of the EOC diagnosis (stage, histology type, treatment). Diagnostic process intervals were based on the Aarhus statement. 1-year and 5-year survival analysis was undertaken.Results Of the 513 patients included in the cohort, 67.2% initially consulted their family physician, while 36.4% were diagnosed through emergency services. In the Cox models, survival was influenced by advanced stage at 1 year (HR 3.84, 95% CI 1.23 to 12.02) and 5 years (HR 5.36, 95% CI 3.07 to 9.36), as was the type of treatment received, although this association was attenuated over follow-up. Age became significant at 5 years of follow-up. After adjusting for age, adjusted morbidity groups, stage at diagnosis and treatment, 5-year survival was better in patients presenting with gynaecological bleeding (HR 0.35, 95% CI 0.16 to 0.79). Survival was not associated with a starting point involving primary care (HR 1.39, 95% CI 0.93 to 2.09), diagnostic pathways involving referral to elective gynaecological care from non-general practitioners (HR 0.80, 95% CI 0.51 to 1.26), or self-presentation to emergency services (HR 0.82, 95% CI 0.52 to 1.31).Conclusions Survival in EOC is not associated with diagnostic pathways or prehospital healthcare, but it is influenced by stage at diagnosis, administration of primary cytoreduction plus chemotherapy and patient age.
format Article
id doaj-art-0efee40181134eacac87604226a2eeb7
institution Kabale University
issn 2044-6055
language English
publishDate 2022-07-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-0efee40181134eacac87604226a2eeb72025-01-31T00:00:14ZengBMJ Publishing GroupBMJ Open2044-60552022-07-0112710.1136/bmjopen-2021-060499Prehospital care for ovarian cancer in Catalonia: could we do better in primary care? Retrospective cohort studyMercè Marzo-Castillejo0Josep M Borras1Carmen Vela-Vallespín2Paula Manchon‐Walsh3Luisa Aliste4Research Support Unit Metropolitana Sud, University Institute for Primary Health Care Research (IDIAP) Jordi Gol, Catalan Health Institut, Cornellà de Llobregat, SpainCatalonian Cancer Strategy, Department of Health, L`Hospitalet de Llobregat, SpainPrimary Health Care Center Riu Nord i Riu Sud, Catalan Institute of Health, Santa Coloma de Gramenet, SpainCatalonian Cancer Strategy, Department of Health, L`Hospitalet de Llobregat, SpainCatalonian Cancer Strategy, Department of Health, L`Hospitalet de Llobregat, SpainObjective To assess the impact of prehospital factors (diagnostic pathways, first presentation to healthcare services, intervals, participation in primary care) on 1-year and 5-year survival in people with epithelial ovarian cancer (EOC).Design Retrospective quasi-population-based cohort study.Setting Catalan Integrated Public Healthcare System.Participants People with EOC who underwent surgery with a curative intent in public Catalan hospitals between 1 January 2013 and 31 December 2014.Outcome measures Data from primary and secondary care clinical histories and care processes in the 18 months leading up to confirmation (signs and symptoms at presentation, diagnosis pathways, referrals, diagnosis interval) of the EOC diagnosis (stage, histology type, treatment). Diagnostic process intervals were based on the Aarhus statement. 1-year and 5-year survival analysis was undertaken.Results Of the 513 patients included in the cohort, 67.2% initially consulted their family physician, while 36.4% were diagnosed through emergency services. In the Cox models, survival was influenced by advanced stage at 1 year (HR 3.84, 95% CI 1.23 to 12.02) and 5 years (HR 5.36, 95% CI 3.07 to 9.36), as was the type of treatment received, although this association was attenuated over follow-up. Age became significant at 5 years of follow-up. After adjusting for age, adjusted morbidity groups, stage at diagnosis and treatment, 5-year survival was better in patients presenting with gynaecological bleeding (HR 0.35, 95% CI 0.16 to 0.79). Survival was not associated with a starting point involving primary care (HR 1.39, 95% CI 0.93 to 2.09), diagnostic pathways involving referral to elective gynaecological care from non-general practitioners (HR 0.80, 95% CI 0.51 to 1.26), or self-presentation to emergency services (HR 0.82, 95% CI 0.52 to 1.31).Conclusions Survival in EOC is not associated with diagnostic pathways or prehospital healthcare, but it is influenced by stage at diagnosis, administration of primary cytoreduction plus chemotherapy and patient age.https://bmjopen.bmj.com/content/12/7/e060499.full
spellingShingle Mercè Marzo-Castillejo
Josep M Borras
Carmen Vela-Vallespín
Paula Manchon‐Walsh
Luisa Aliste
Prehospital care for ovarian cancer in Catalonia: could we do better in primary care? Retrospective cohort study
BMJ Open
title Prehospital care for ovarian cancer in Catalonia: could we do better in primary care? Retrospective cohort study
title_full Prehospital care for ovarian cancer in Catalonia: could we do better in primary care? Retrospective cohort study
title_fullStr Prehospital care for ovarian cancer in Catalonia: could we do better in primary care? Retrospective cohort study
title_full_unstemmed Prehospital care for ovarian cancer in Catalonia: could we do better in primary care? Retrospective cohort study
title_short Prehospital care for ovarian cancer in Catalonia: could we do better in primary care? Retrospective cohort study
title_sort prehospital care for ovarian cancer in catalonia could we do better in primary care retrospective cohort study
url https://bmjopen.bmj.com/content/12/7/e060499.full
work_keys_str_mv AT mercemarzocastillejo prehospitalcareforovariancancerincataloniacouldwedobetterinprimarycareretrospectivecohortstudy
AT josepmborras prehospitalcareforovariancancerincataloniacouldwedobetterinprimarycareretrospectivecohortstudy
AT carmenvelavallespin prehospitalcareforovariancancerincataloniacouldwedobetterinprimarycareretrospectivecohortstudy
AT paulamanchonwalsh prehospitalcareforovariancancerincataloniacouldwedobetterinprimarycareretrospectivecohortstudy
AT luisaaliste prehospitalcareforovariancancerincataloniacouldwedobetterinprimarycareretrospectivecohortstudy